Patient Safety and Quality, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, United States.
General Internal Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States.
Appl Clin Inform. 2020 May;11(3):487-496. doi: 10.1055/s-0040-1714276. Epub 2020 Jul 22.
Alert presentation of clinical decision support recommendations is a common method for providing information; however, many alerts are overridden suggesting presentation design improvements can be made. This study attempts to assess pediatric prescriber information needs for drug-drug interactions (DDIs) alerts and to evaluate the optimal presentation timing and presentation in the medication ordering process.
Six case scenarios presented interactions between medications used in pediatric specialties of general medicine, infectious disease, cardiology, and neurology. Timing varied to include alert interruption at medication selection versus order submission; or was noninterruptive. Interviews were audiotaped, transcribed, and independently analyzed to derive central themes.
Fourteen trainee and attending clinicians trained in pediatrics, cardiology, and neurology participated. Coders derived 8 central themes from 929 quotes. Discordance exists between medication prescribing frequency and DDI knowledge; providers may commonly prescribe medications for which they do not recognize DDIs. Providers wanted alerts at medication selection rather than at order signature. Alert presentation themes included standardizing text, providing interaction-specific incidence/risk information, DDI rating scales, consolidating alerts, and providing alternative therapies. Providers want alerts to be actionable, for example, allowing medication discontinuation and color visual cues for essential information. Despite alert volume, participants did not "mind being reminded because there is always the chance that at that particular moment (they) do not remember it" and acknowledged the importance of alerts as "essential in terms of patient safety."
Clinicians unanimously agreed on the importance of receiving DDI alerts to improve patient safety. The perceived alert value can be improved by incorporating clinician preferences for timing and presentation.
临床决策支持建议的警示呈现是提供信息的常用方法;然而,许多警示被忽略,这表明呈现设计可以进行改进。本研究旨在评估儿科处方者对药物相互作用(DDI)警示的信息需求,并评估在药物医嘱流程中最佳的呈现时间和呈现方式。
呈现了六种儿科医学专业(普通医学、传染病学、心脏病学和神经病学)中使用的药物之间的相互作用案例场景。警示呈现的时机包括在药物选择时中断与在医嘱提交时中断,或者是非中断的。访谈进行了录音、转录,并进行了独立分析以得出核心主题。
14 名接受儿科、心脏病学和神经病学培训的住院医师和主治医生参与了研究。编码员从 929 条引语中得出了 8 个核心主题。药物处方频率与 DDI 知识之间存在不一致;提供者可能经常开他们不认识的 DDI 的药物。提供者希望在药物选择时而不是在医嘱签名时出现警示。警示呈现主题包括标准化文本、提供交互特定的发生率/风险信息、DDI 评级量表、整合警示和提供替代疗法。提供者希望警示是可操作的,例如允许停药和对重要信息进行颜色视觉提示。尽管警示数量多,但参与者并不“介意被提醒,因为总有那么一刻(他们)可能不记得了”,并承认警示的重要性,“在患者安全方面至关重要”。
临床医生一致认为,为了提高患者安全性,接收 DDI 警示非常重要。通过纳入临床医生对时间和呈现方式的偏好,可以提高警示的感知价值。